1,401,923 filings since 2004 · latest accepted Nov 3, 2026, 5:27 PM ET
Priority items usually mark a change in credit, accounting integrity, control or listing status: 1.02 Agreement terminated, 1.03 Bankruptcy, 1.05 Cybersecurity incident, 2.04 Debt acceleration, 2.05 Restructuring costs, 2.06 Impairment, 3.01 Delisting notice, 4.01 Auditor change, 4.02 Non-reliance (restatement), 5.01 Change in control.
| Filed | Company | Items | Filing |
|---|---|---|---|
Apr 15, 2025 accepted 4:06 PM ET | TVRDTvardi Therapeutics, Inc. | 1.01Material agreement2.01Acquisition / disposition3.03Holder rights modified5.01Change in control5.02Officer / director change5.03Bylaws / fiscal yearCode of ethics |
Source: SEC EDGAR. Same-day filings appear within minutes and are re-checked against SEC's nightly index. Tickers are current listings, so a company's older filings show its ticker today.
| DocumentSEC ↗ |
Dec 18, 2024 accepted 7:23 AM ET | TVRDTvardi Therapeutics, Inc. | 1.01Material agreement5.01Change in control5.02Officer / director change8.01Other events | DocumentSEC ↗ |
Nov 2, 2023 accepted 7:10 AM ET | TVRDTvardi Therapeutics, Inc. | 1.01Material agreement7.01Reg FD disclosure | DocumentSEC ↗ |
Aug 4, 2021 accepted 5:31 PM ET | TVRDTvardi Therapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
Oct 20, 2020 accepted 6:30 AM ET | TVRDTvardi Therapeutics, Inc. | 1.01Material agreement3.02Unregistered equity sale7.01Reg FD disclosure | DocumentSEC ↗ |
Aug 21, 2019 accepted 8:02 AM ET | TVRDTvardi Therapeutics, Inc. | 1.01Material agreement3.02Unregistered equity sale8.01Other events | DocumentSEC ↗ |
Jul 12, 2019 accepted 4:10 PM ET | TVRDTvardi Therapeutics, Inc. | 1.01Material agreement | DocumentSEC ↗ |
May 23, 2018 accepted 6:06 AM ET | TVRDTvardi Therapeutics, Inc. | 1.01Material agreement3.02Unregistered equity sale | DocumentSEC ↗ |
Dec 23, 2015 accepted 4:01 PM ET | TVRDTvardi Therapeutics, Inc. | 1.01Material agreement2.03New debt obligation | DocumentSEC ↗ |